The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 18, Issue 2, Pages 218-230
Publisher
Wiley
Online
2013-11-25
DOI
10.1111/jcmm.12153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined gene expression and proteomic analysis of EGF induced apoptosis in A431 cells suggests multiple pathways trigger apoptosis
- (2013) Ibrahim Alanazi et al. APOPTOSIS
- The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer
- (2013) S.K. Gantsev et al. BIOMEDICINE & PHARMACOTHERAPY
- EGF Receptor Activates MET through MAPK to Enhance Non-Small Cell Lung Carcinoma Invasion and Brain Metastasis
- (2013) J. L. Breindel et al. CANCER RESEARCH
- Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts
- (2013) Yonghua Zheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Slug promoted vasculogenic mimicry in hepatocellular carcinoma
- (2013) Dan Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Novel Statistical Prognostic Score Model That Includes Serum CXCL5 Levels and Clinical Classification Predicts Risk of Disease Progression and Survival of Nasopharyngeal Carcinoma Patients
- (2013) Haibo Zhang et al. PLoS One
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
- (2012) Yan Ning et al. MOLECULAR CANCER THERAPEUTICS
- Potential anticancer therapiesviaCXCL5 and its receptors
- (2012) Xiaojing Xu et al. Expert Review of Clinical Pharmacology
- STAT3 activation in monocytes accelerates liver cancer progression
- (2011) Wen-Yong Wu et al. BMC CANCER
- Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor
- (2011) Jennifer L. Halpern et al. CANCER LETTERS
- CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
- (2011) Mikio Kawamura et al. EUROPEAN JOURNAL OF CANCER
- Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells
- (2011) Yaohui Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Potential mechanism of interleukin-8 production from lung cancer cells: An involvement of EGF-EGFR-PI3K-Akt-Erk pathway
- (2011) Yong Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma
- (2011) Olorunseun O Ogunwobi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment
- (2011) Pavani Gangavarapu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
- (2011) Ken Shirabe et al. SURGERY TODAY
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells
- (2010) Hui Liu et al. Cellular & Molecular Immunology
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
- (2010) Ju Dong Yang et al. SEMINARS IN CANCER BIOLOGY
- The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer
- (2009) Carmen Berasain et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
- (2009) Vincent Wai-Sun Wong et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
- (2009) Valerie Chew et al. JOURNAL OF HEPATOLOGY
- Enhanced Expression and Clinical Significance of Chemokine Receptor CXCR2 in Hepatocellular Carcinoma
- (2009) Zhen Liu et al. JOURNAL OF SURGICAL RESEARCH
- Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
- (2009) Mohamed IF Shariff et al. Expert Review of Gastroenterology & Hepatology
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
- (2008) Anne F. Buckley et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started